Nantahala Capital Management LLC trimmed its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 17.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 935,122 shares of the company's stock after selling 200,000 shares during the quarter. Nantahala Capital Management LLC owned about 2.40% of Viemed Healthcare worth $7,500,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. R Squared Ltd acquired a new stake in Viemed Healthcare during the 4th quarter worth approximately $41,000. EntryPoint Capital LLC acquired a new stake in shares of Viemed Healthcare during the fourth quarter worth $92,000. Prudential Financial Inc. bought a new stake in shares of Viemed Healthcare in the fourth quarter valued at about $93,000. Oxford Asset Management LLP acquired a new position in shares of Viemed Healthcare in the fourth quarter valued at about $98,000. Finally, Price T Rowe Associates Inc. MD increased its position in Viemed Healthcare by 18.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,005 shares of the company's stock worth $105,000 after acquiring an additional 1,997 shares during the period. 74.24% of the stock is currently owned by institutional investors and hedge funds.
Viemed Healthcare Stock Performance
Viemed Healthcare stock traded up $0.31 during midday trading on Friday, hitting $7.37. The company's stock had a trading volume of 194,288 shares, compared to its average volume of 139,546. The company has a 50-day moving average price of $7.16 and a two-hundred day moving average price of $8.01. Viemed Healthcare, Inc. has a 1-year low of $6.21 and a 1-year high of $9.81. The company has a market cap of $291.29 million, a price-to-earnings ratio of 27.30 and a beta of 1.64. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
See Also
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
